Pharmaceuticals & Drugs
|Market Cap||144 Cr||EPS||-2.7||High||35.8|
|Stock P/E||0.0||Net Profit Margin||NA||Low||33.8|
|Market Cap||144 Cr||ROE||-3.5%|
|P/B Ratio||1.1||Dividend Yield||0.7%|
|Industry P/E||64.4||Book Value||31.9|
About the Company
Lasa Supergenerics (Lasa) is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing. Lasa group is a veterinary API manufacturing entity, which was acquired in April 2012. The manufacturing base of Lasa group is located at Mahad, in the Konkan region of Maharashtra. It specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India. To efficiently control the supply chain, the group backward integrated its key molecules-from discovery research up to full-scale bulk production.
Lasa group’s marketing footprint is entrenched across developing markets in multiple countries. Similarly, the group expects to augment its export footprint significantly in width and depth in the future. The group has alliances with leading Indian and global animal health care conglomerates, and uses Good Manufacturing Practice (GMP) and world-class technologies in its operations.
Business area of the company
The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India
|Parent Organisation||Lasa Supergenerics Ltd.||Managing Director||Omkar Pravin Herlekar|
|Company||52 Week||Market Price||P/E Ratio|
Frequently asked questions